GlaxoSmithKline (GSK) has announced it is to begin searching for a successor to CEO Andrew Witty, who will retire in just over a year's time. Witty has told GSK's board that he intends to retire ...
GSK also faced U.S. government investigations ... Since the assassination of his top lieutenant Brian Thompson on Dec. 4, ...
GlaxoSmithKline’s (GSK) former chief executive Andrew Witty was yesterday announced as the new CEO of Optum – a US payer organisation which includes pharmacy benefits manager OptumRx.
The big picture: UnitedHealth Group CEO Andrew Witty spoke at length Thursday about ... The intrigue: Witty is a former CEO of British drug company GSK. During his tenure there, he told CNBC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback